In an era of increasingly individualized healthcare, Elizabeth Philp has become a formidable figure of innovation, especially in the technologically advancing field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a drive to make bespoke medications more available, questioning the conventi